Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis

ISSN： 1460-2156

Source： Brain, Vol.136, Iss.4, 2013-04, pp. : 1067-1082

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis

By Rodriguez M.

Brain, Vol. 126, Iss. 4, 2003-04 ,pp. : 751-752

Oxford University Press

Access to resources Recommend Favorite

Threshold electrotonus in peripheral motor axons in multiple sclerosis

By Cikurel K. Caponnetto C. Brusa A. Kapoor R. Murray N.M.F. Bostock H.

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 172-173

Elsevier

Access to resources Recommend Favorite

Mitochondrial changes within axons in multiple sclerosis

By Mahad Don J.

Brain, Vol. 132, Iss. 5, 2009-05 ,pp. : 1161-1174

Oxford University Press

Access to resources Recommend Favorite

Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?

By Charles P.

Brain, Vol. 125, Iss. 9, 2002-09 ,pp. : 1972-1979

Oxford University Press

Access to resources Recommend Favorite

Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis

By Wolswijk G. Balesar R.

Brain, Vol. 126, Iss. 7, 2003-07 ,pp. : 1638-1649

Oxford University Press

Access to resources Recommend Favorite